Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Inhibrx Biosciences Inc (INBX)

Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Inhibrx Biosciences Inc 11025 N. TORREY PINES ROAD SUITE 140 LA JOLLA CA 92037 USA

https://inhibrx.com Employees: 161 P: 858-795-4220

Sector:

Medical

Description:

Inhibrx Inc. is a clinical-stage biopharmaceutical company. It focused on developing a broad pipeline of novel biologic therapeutic candidates in oncology and orphan diseases. Inhibrx Inc. is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 1,292,815
Enterprise Value, $K 1,140,215
Shares Outstanding, K 14,544
Annual Sales, $ 200 K
Annual Net Income, $ 1,688 M
Last Quarter Sales, $ 1,300 K
Last Quarter Net Income, $ -28,650 K
EBIT, $ -191,630 K
EBITDA, $ -189,340 K
60-Month Beta 1.18
% of Insider Shareholders 17.09%
% of Institutional Shareholders 82.46%
Float, K 12,058
% Float 82.91%
Short Volume Ratio 0.39

Growth:

1-Year Return 464.53%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.28 on 11/14/25
Next Earnings Date 03/16/26
Earnings Per Share ttm -10.58
EPS Growth vs. Prev Qtr -23.24%
EPS Growth vs. Prev Year 19.72%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

INBX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -186.06%
Return-on-Assets % -76.30%
Profit Margin % 843,784.96%
Debt/Equity 1.45
Price/Sales 6,800.05
Price/Cash Flow 0.80
Price/Book 36.78
Book Value/Share 4.73
Interest Coverage 126.10
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar